Posted on Friday, September 22, 2017 at 10:31 am CDT
According to Transparency Market Research (TMR), the global Alzheimer's drugs market is expected to exhibit a consistent 7.5% CAGR in the 2017-2025 forecast period. The market's revenue was valued at more than US$3.6 bn in 2017 and is expected to rise to US$6.4 bn by 2025.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 11:21 am CDT
The global elder care services market over an eight year period. Estimated figures indicate significant growth prospects in the global market, providing good opportunities for business expansion and revenue generation for seasoned market players as well as market entrants.
Source: Persistence Market Research
Posted on Friday, September 22, 2017 at 10:33 am CDT
As per a report by Transparency Market Research, the global ophthalmic drugs market will likely attain a value of US$34.3 bn by 2025 from US$24.4 bn in 2016 by registering a tepid CAGR of 4.0% from 2017 to 2025.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 10:35 am CDT
The global market for chlamydia infection diagnostics and therapeutics stood at US$1,195.5 mn in 2016 and is projected to rise at a CAGR of 6.0% from 2017 to 2025 to reach a valuation of US$2,002.2 mn in 2025.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 8:59 am CDT
Transparency Market Research in a recent publication says competition in the global dilated cardiomyopathy therapeutics market is expected to grow as prominent companies strive to develop effective drugs for the treatment of dilated cardiomyopathy. For example, in February 2017, Myokardia Inc., a biopharmaceutical company, announced first time administer of MYK-491 to a batch of healthy subjects. MYK-491 is a treatment for dilated cardiomyopathy which is in Phase 1.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:01 am CDT
The global PAH market is estimated to reach a valuation of US$5.19 bn by the end of 2020, expanding at a tremendous CAGR of 17.90% between 2014 and 2020.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 10:37 am CDT
TMR's report predicts that the international veterinary hematology analyzers market could showcase a 6.7% CAGR between the forecast period of 2016 to 2024. The market stood at US$663.0 mn in 2015 and is projected to reach a valuation of US$1,178.9 mn by the end of the forecast period.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 10:39 am CDT
The global market for surgical sutures will exhibit a 3.9% CAGR from 2017 to 2025, rising to a valuation of US$5,080.1 mn by 2025.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:03 am CDT
The MEA defibrillator is expected to grow at a CAGR of 7.60% between the aforementioned forecast period. The overall valuation of the defibrillator market in the Middle East and Africa is estimated to reach the valuation of US$547.8 mn by the fall of 2020 according to the report.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:05 am CDT
As per the evaluations of the TMR report, the global constipation treatment market was worth US$12.58 bn in 2016. During the forecast period of 2017 to 2025, the TMR report projects the global constipation treatment market to exhibit a healthy CAGR of 7.1%, estimating it to reach an overall valuation of US$22.93 bn by 2025.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:07 am CDT
According to this market research report, factors that drive the global ostomy drainage bags market are rapidly growing geriatric population and the rising incidence of ulcerative colitis, IBD, Crohn's disease, bladder cancer, and colorectal cancer. Ostomy draining bags refer to prosthetic medical devices that are used for collecting bodily wastes that get excreted after an Ostomy procedure. In this procedure, wastes are diverted from biological systems such as the bladder, ileum, and the colon into an abdominal stoma that is created manually.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:09 am CDT
The global market for G-protein coupled receptors is expected to rise at a CAGR of 8.8% from 2014 to 2022. The market was worth US$1.63 bn in 2013 and is expected to rise to a valuation of US$3.53 bn by the end of 2022." In terms of therapeutic areas, the market is anticipated to be led by oncology in the years ahead owing to the rising number of cases of cancer. Region-wise, the market is most probably to be led by North America closely led by Europe due to the rise in the case of obesity in these regions.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:11 am CDT
Glioblastoma multiforme (GBM) is the most lethal and common brain tumor in adults. The treatment modalities available in the market at present include surgical resection, followed by radiotherapy and chemotherapy. Despite being around in the healthcare industry since the last few years, these modalities have done little to decrease the overall mortality rate in patients. Recurrence of disease, glioma stem cell resistance to conventional modalities, and invasiveness of GBM are a few factors hampering the success rate of available treatment methods.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:13 am CDT
As per the report, the anti-aging market in Asia, Europe, and South America is majorly fuelled by the increasing number of baby boomers, thus increasing the demand for various methods of curbing and reversing the prominent signs of aging. The market is continuously growing and a number of products, devices, and services have entered the market in recent years due to the consistent demand to lessen the signs of aging. Amongst these, in 2013, the anti-aging products held the biggest share in the anti-aging market due to increasing awareness amongst people and the economical prices of these products.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:15 am CDT
The global market for cardiopulmonary stress testing systems is anticipated to witness an 8.20% from 2015 to 2023 rising from a valuation of US$3.30 bn in 2014 to a valuation of US$6.67 bn by the end of 2023." Based on product type, the global market for cardiopulmonary stress testing systems was led by CPET systems owing to the critical part this non-invasive plays for ascertaining skeletal, cardiovascular, hematopoietic, neuropsychological, and pulmonary muscle systems' retort to exercise. Technological advancements are also likely to play a crucial role in the development of this segment. Regionally, North America is likely to witness a strong 7.3% CAGR over the forecast period and also rule the market meanwhile owing to the rising number cases of obesity in the region. The prevalence of leading players in North America is also likely to add up to the scenario.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 11:47 am CDT
The opportunity in the global cosmetic skin care market was pegged at US$127.1 bn in 2015. Expanding at a 5.1% CAGR from 2016 to 2024, the market is projected to be worth just over US$200 bn by the end of the forecast period. By type of product, the market is led by anti-aging products and this segment is likely to retain its position throughout the forecast period, amounting to over US$44 bn by 2024.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:17 am CDT
With these collaborative efforts of market players, the Saudi Arabia defibrillators market is expected to be worth US$49.8 mn by 2020 steadily rising at a CAGR of 8.3% from US$28.6 mn in 2013. The market will be driven by the ALS defibrillators segment as the opportunity in this product segment is anticipated to reach US$36.5 mn by 2020. An increasing adoption of ALS defibrillators in the ever-expanding healthcare sector has created a remarkable opportunity for this product segment over the past few years. However, the affordability of AEDs is expected to propel this segment as well.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:19 am CDT
As per the projections of the TMR report, the demand in the global alpha-1 antitrypsin deficiency treatment market will augment at formidable CAGR of 10.3% during the forecast period of 2017 to 2025, estimated to reach a valuation of US$2,908.1 mn by the end of 2025, remarkably up from its evaluated worth of US$1,224.5 mn in 2016. In the near future, a number of new biotechnology companies are expected to have a foray in the alpha-1 antitrypsin deficiency treatment market, developing novel treatment processes, personalized medicines for genetically inherited disorders, and invest on the research and development of stem cell based therapeutics.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:21 am CDT
As per a report by Transparency Market Research, the global bioengineered protein drugs market will rise at a 7.4% CAGR during the period between 2017 and 2024 to become worth US$336.9 bn by 2025 from US$177.7 bn in 2016.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:23 am CDT
A report by Transparency Market Research predicts the global market for thin film manufacturing to rise at a healthy CAGR of 9.0%. At this rate, the market, which was worth US$7.338 bn in 2015 is expected to become worth US$15.984 bn by 2024.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:25 am CDT
According to the research report, the global market for ileostomy stood at US$765.2 mn in 2015. Proliferating at a CAGR of 8.90% over the period from 2016 to 2024, the market is anticipated to attain a value of US$1.65 bn by the end of the forecast period. The demand for stoma bags is much higher than other equipment and the trend is anticipated to remain so over the period of the forecast, states the report.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:27 am CDT
The opportunity in the global transdermal scopolamine market was pegged at US$330.0 mn in 2015 and is poised to reach a valuation of US$585.3 mn by the end of 2024, progressing at a healthy CAGR of 6.70% between 2016 and 2024.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:29 am CDT
The global cartilage degeneration market was valued at US$9.5 Bn in 2016 and is projected to reach a market value of US$14.7 Bn in 2025, expanding at a CAGR of 5.6% from 2017 to 2025.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:31 am CDT
The TMR report detects that vendors operating in the global insulin delivery devices market are coping up with the intense competition via pricing and the development of devices that differentiates them from their competitors. In the near future, strategic alliances, particularly with mushrooming number of diabetic clinics, aggressive marketing, and providing home services to the patients are expected to help the companies to gain market shares. For example, Medtronic and Sanofi collaborated in June 2014 to develop drug-device combinations for diabetic patients. In this partnership, Medtronic brought its expertise in glucose monitoring and pump therapy while Sanofi are known for their wide-ranging insulin products.
Source: Transparency Market Research
Posted on Friday, September 22, 2017 at 9:33 am CDT
The global dental implants market is projected to expand at a modest CAGR of 6.9% between 2017 and 2025. This will result in the market to become worth US$6.54 bn by 2025 increasing from its valuation of US$3.60 bn in 2016.
Source: Transparency Market Research